Switch theme
Sign up to access all valuation multiples
Synthaverse SA is a global pharmaceutical company. Its goal is to provide the best, innovative and unique solutions for medicine. Its work is based on scientific and health knowledge. Along with its expert approach, it allows the company to create reliable and unique products. It manufactures one of the few drugs used internationally in the oncological immunotherapy of bladder cancer.
1944
221
LTM Revenue $21.4M
LTM EBITDA $7.5M
$122M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Synthaverse has a last 12-month revenue (LTM) of $21.4M and a last 12-month EBITDA of $7.5M.
In the most recent fiscal year, Synthaverse achieved revenue of $19.9M and an EBITDA of $3.5M.
Synthaverse expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Synthaverse valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $21.4M | XXX | $19.9M | XXX | XXX | XXX |
| Gross Profit | n/a | XXX | $12.3M | XXX | XXX | XXX |
| Gross Margin | n/a | XXX | 62% | XXX | XXX | XXX |
| EBITDA | $7.5M | XXX | $3.5M | XXX | XXX | XXX |
| EBITDA Margin | 35% | XXX | 18% | XXX | XXX | XXX |
| EBIT | $4.0M | XXX | $3.5M | XXX | XXX | XXX |
| EBIT Margin | 19% | XXX | 17% | XXX | XXX | XXX |
| Net Profit | $2.6M | XXX | $2.1M | XXX | XXX | XXX |
| Net Margin | 12% | XXX | 11% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $21.1M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 16, 2025, Synthaverse's stock price is PLN 5 (or $1).
Synthaverse has current market cap of PLN 362M (or $100M), and EV of PLN 437M (or $122M).
See Synthaverse trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $122M | $100M | XXX | XXX | XXX | XXX | $0.09 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 16, 2025, Synthaverse has market cap of $100M and EV of $122M.
Synthaverse's trades at 6.1x EV/Revenue multiple, and 34.3x EV/EBITDA.
Equity research analysts estimate Synthaverse's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Synthaverse has a P/E ratio of 38.1x.
See valuation multiples for Synthaverse and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $100M | XXX | $100M | XXX | XXX | XXX |
| EV (current) | $122M | XXX | $122M | XXX | XXX | XXX |
| EV/Revenue | 5.7x | XXX | 6.1x | XXX | XXX | XXX |
| EV/EBITDA | 16.3x | XXX | 34.3x | XXX | XXX | XXX |
| EV/EBIT | 30.2x | XXX | 35.2x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | 38.1x | XXX | 47.9x | XXX | XXX | XXX |
| EV/FCF | 50.2x | XXX | 29.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialSynthaverse's last 12 month revenue growth is 45%
Synthaverse's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $40K for the same period.
Synthaverse's rule of 40 is 71% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Synthaverse's rule of X is 148% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Synthaverse and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 45% | XXX | 39% | XXX | XXX | XXX |
| EBITDA Margin | 35% | XXX | 18% | XXX | XXX | XXX |
| EBITDA Growth | 90% | XXX | 50% | XXX | XXX | XXX |
| Rule of 40 | 71% | XXX | 63% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 148% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $40K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 10% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 44% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Synthaverse acquired XXX companies to date.
Last acquisition by Synthaverse was XXXXXXXX, XXXXX XXXXX XXXXXX . Synthaverse acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Synthaverse founded? | Synthaverse was founded in 1944. |
| Where is Synthaverse headquartered? | Synthaverse is headquartered in Poland. |
| How many employees does Synthaverse have? | As of today, Synthaverse has 221 employees. |
| Is Synthaverse publicy listed? | Yes, Synthaverse is a public company listed on WAR. |
| What is the stock symbol of Synthaverse? | Synthaverse trades under SVE ticker. |
| When did Synthaverse go public? | Synthaverse went public in 2011. |
| Who are competitors of Synthaverse? | Similar companies to Synthaverse include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of Synthaverse? | Synthaverse's current market cap is $100M |
| What is the current revenue of Synthaverse? | Synthaverse's last 12 months revenue is $21.4M. |
| What is the current revenue growth of Synthaverse? | Synthaverse revenue growth (NTM/LTM) is 45%. |
| What is the current EV/Revenue multiple of Synthaverse? | Current revenue multiple of Synthaverse is 5.7x. |
| Is Synthaverse profitable? | Yes, Synthaverse is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Synthaverse? | Synthaverse's last 12 months EBITDA is $7.5M. |
| What is Synthaverse's EBITDA margin? | Synthaverse's last 12 months EBITDA margin is 35%. |
| What is the current EV/EBITDA multiple of Synthaverse? | Current EBITDA multiple of Synthaverse is 16.3x. |
| What is the current FCF of Synthaverse? | Synthaverse's last 12 months FCF is $2.4M. |
| What is Synthaverse's FCF margin? | Synthaverse's last 12 months FCF margin is 11%. |
| What is the current EV/FCF multiple of Synthaverse? | Current FCF multiple of Synthaverse is 50.2x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
